Novavax expects Phase 4 Covid trial to cost up to $90Mnews2025-08-06T18:05:52+00:00August 6th, 2025|Endpoints News|
BridgeBio’s Attruby sales underwhelm Wall Street despite growthnews2025-08-06T15:45:32+00:00August 6th, 2025|Endpoints News|
Amgen CEO says compounding is ‘less a direct issue’ for obesity drug MariTidenews2025-08-06T15:23:26+00:00August 6th, 2025|Endpoints News|
Merck was the only bidder for Verona before the $10B buyoutnews2025-08-06T14:49:23+00:00August 6th, 2025|Endpoints News|
Bayer has laid off 12,000 staffers so far — with more to comenews2025-08-06T11:08:59+00:00August 6th, 2025|Endpoints News|
Novo Nordisk’s pipeline cull prompts hopes of strategic shiftnews2025-08-06T10:39:45+00:00August 6th, 2025|Endpoints News|
AstraZeneca culls plans for Evusheld successor in the US following Covid evolutionnews2025-08-06T01:29:00+00:00August 6th, 2025|Endpoints News|
Kennedy says BARDA will cancel 22 mRNA vaccine contractsnews2025-08-05T23:01:56+00:00August 5th, 2025|Endpoints News|
Makary has asked Prasad to ‘reconsider’ departure from FDAnews2025-08-05T18:25:32+00:00August 5th, 2025|Endpoints News|
Specialty pharma SERB to buy Y-mAbs in $412M all-cash dealnews2025-08-05T18:17:35+00:00August 5th, 2025|Endpoints News|
